Article Details
Retrieved on: 2022-05-12 23:39:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
PHESGO is the world's first fixed dose combination of two monoclonal antibodies Perjeta (pertuzumab) and Herceptin (trastuzumab) in Oncology for ...
Article found on: economictimes.indiatimes.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here